Personality as a predictor of disability in multiple sclerosis. Arch Clin Neuropsychol. 2023;38(5):657–66. Article PubMed PubMed Central Google Scholar Kever A, Walker ELS, Riley CS, Heyman RA, Xia Z, Leavitt VM. Association of personality traits with physical function, cognition, and ...
The Multiple Sclerosis Drugs market [geoPrepName] is projected to grow by 1.16% (2024-2029) resulting in a market volume of US$41.90m in 2029.
Multiple sclerosis (MS) is an autoimmune condition that damages the protective myelin covering of nerves. Reviewed by a board-certified neurologist.
We conducted a cohort study by linking nationwide data from the Danish Multiple Sclerosis Registry to the Population Statistics Registry, the Danish Cause of Death Registry, and the Historical Migration Registry. We included all living patients with a confirmed multiple sclerosis diagnosis who lived in...
Multiple sclerosis (MS) is a neuro-inflammatory and neurodegenerative disease that is most prevalent in Northern Europe. Although it is known that inherited risk for MS is located within or in close proximity to immune-related genes, it is unknown when,
Statistics Marketing Unclassified [#IABV2_LABEL_PURPOSES#] [#IABV2_LABEL_FEATURES#] [#IABV2_LABEL_PARTNERS#] Home»Blog»Multiple Sclerosis Biomarkers: The Future of Disease Detection and Management Key Takeaways Blood-biomarker detection allows for accessible and cost-effectivescreening ...
We present a study of multiple sclerosis segmentation algorithms conducted at the international MICCAI 2016 challenge. This challenge was operated using a new open-science computing infrastructure. This allowed for the automatic and independent evaluatio
A slice of magnetic resonance imaging scan of a patient with multiple sclerosis showing characteristic periventricular lesions with increased signal on T2-weighted (A) and proton-density (B) images. A gadolinium-enhanced magnetic resonance imaging scan did not show enhancing lesions, but some of the...
About Multiple Sclerosis Trust (MS Trust) The MS Trust is a UK charity which is here to help everyone make sense of MS. We are here for everyone affected by MS, from the moment of diagnosis and throughout their journey. We're here today, tomorrow and every day after that. ...
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) that results in significant neurodegeneration in the majority of those affected and is a common cause of chronic neurological disability in young adults1,2. Here, to pro